These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38042762)

  • 21. Identification of macrotrabecular-massive hepatocellular carcinoma through multiphasic CT-based representation learning method.
    Zhang Z; Zhang W; He C; Xie J; Liang F; Zhao Y; Tan L; Lai S; Jiang X; Wei X; Zhen X; Yang R
    Med Phys; 2024 Dec; 51(12):9017-9030. PubMed ID: 39311438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
    Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.
    Shi ZX; Li CF; Zhao LF; Sun ZQ; Cui LM; Xin YJ; Wang DQ; Kang TR; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):361-369. PubMed ID: 37429785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
    Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
    Zhang C; Ma LD; Zhang XL; Lei C; Yuan SS; Li JP; Geng ZJ; Li XM; Quan XY; Zheng C; Geng YY; Zhang J; Zheng QL; Hou J; Xie SY; Lu LH; Xie CM
    J Magn Reson Imaging; 2024 Jul; 60(1):231-242. PubMed ID: 37888871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma.
    Zheng J; Du PZ; Yang C; Tao YY; Li L; Li ZM; Yang L
    Abdom Radiol (NY); 2023 Nov; 48(11):3343-3352. PubMed ID: 37495746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
    Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
    J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic resonance imaging radiomics nomogram.
    Yang X; Yuan C; Zhang Y; Li K; Wang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32584. PubMed ID: 36596081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.
    Che F; Xu Q; Li Q; Huang ZX; Yang CW; Wang LY; Wei Y; Shi YJ; Song B
    World J Gastroenterol; 2022 Apr; 28(14):1479-1493. PubMed ID: 35582676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Liang Y; Xu F; Wang Z; Tan C; Zhang N; Wei X; Jiang X; Wu H
    Eur J Radiol; 2022 Aug; 153():110356. PubMed ID: 35623312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Shan Y; Yu X; Yang Y; Sun J; Wu S; Mao S; Lu C
    J Hepatocell Carcinoma; 2022; 9():717-728. PubMed ID: 35974953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection.
    Zhang L; Hu J; Hou J; Jiang X; Guo L; Tian L
    Abdom Radiol (NY); 2021 Aug; 46(8):3845-3854. PubMed ID: 33733337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
    Ma Y; Gong Y; Qiu Q; Ma C; Yu S
    BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Feng Z; Li H; Zhao H; Jiang Y; Liu Q; Chen Q; Wang W; Rong P
    Radiology; 2021 Jul; 300(1):219-229. PubMed ID: 33973839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS.
    Luo M; Liu X; Yong J; Ou B; Xu X; Zhao X; Liang M; Zhao Z; Ruan J; Luo B
    Eur Radiol; 2023 Jun; 33(6):4024-4033. PubMed ID: 36484835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Kang HJ; Kim H; Lee DH; Hur BY; Hwang YJ; Suh KS; Han JK
    Radiology; 2021 Sep; 300(3):572-582. PubMed ID: 34227881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.